Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Sept 2015

Reinhold William C, Sunshine Margot, Varma Sudhir, Doroshow James H, Pommier Yves

Abstract excerpt

The NCI-60 cancer cell line panel provides a premier model for data integration, and systems pharmacology being the largest publicly available database of anticancer drug activity, genomic, molecular, and phenotypic data. It comprises gene expression (25,722 transcripts), microRNAs (360 miRNAs), whole-genome DNA copy number (23,413 genes), whole-exome sequencing (variants for 16,568 genes), protein levels (94...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Computational Biology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Factual

Share to Drug Discovery

Share to High-Throughput Nucleotide Sequencing

Share to Software

Share to Web Browser

Source

Open in PubMed Open full text

Identifiers

PMID: 26048278
DOI: 10.1158/1078-0432.CCR-15-0335
PMCID: PMC4558215

Genes

PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60.PMID 26048278Read ↗

NCI-60 whole exome sequencing and pharmacological CellMiner analyses.Semantic proximity Read ↗

rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in RSemantic proximity Read ↗

RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDBSemantic proximity Read ↗

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.Semantic proximity Read ↗

Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.Semantic proximity Read ↗

CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell LinesSemantic proximity Read ↗

CancerResource--updated database of cancer-relevant proteins, mutations and interacting drugs.Semantic proximity Read ↗

Identifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbations.Semantic proximity Read ↗

Interactive webtool for analyzing drug sensitivity and resistance associated with genetic signatures of cancer cell linesSemantic proximity Read ↗

PharmacoDB 2.0 : Improving scalability and transparency of <i>in vitro</i> pharmacogenomics analysisSemantic proximity Read ↗

A Landscape of Pharmacogenomic Interactions in Cancer.Semantic proximity Read ↗

Cancer driver drug interaction explorer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.